Aberrant upregulation of GRB7 expression was also strongly associated with decreased survival in patients with breast cancer [11], and a multi-variate analysis revealed that GRB7 protein overexpression was an independent adverse prognostic factor for breast cancer-free interval [9]. Here, GRB7 is linked to breast carcinoma.